155 related articles for article (PubMed ID: 22218671)
1. Sleep disturbance in alcoholism: proposal of a simple measurement, and results from a 24-week randomized controlled study of alcohol-dependent patients assessing acamprosate efficacy.
Perney P; Lehert P; Mason BJ
Alcohol Alcohol; 2012; 47(2):133-9. PubMed ID: 22218671
[TBL] [Abstract][Full Text] [Related]
2. Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects.
Staner L; Boeijinga P; Danel T; Gendre I; Muzet M; Landron F; Luthringer R
Alcohol Clin Exp Res; 2006 Sep; 30(9):1492-9. PubMed ID: 16930211
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of acamprosate for alcohol dependence in a family medicine setting in the United States: a randomized, double-blind, placebo-controlled study.
Berger L; Fisher M; Brondino M; Bohn M; Gwyther R; Longo L; Beier N; Ford A; Greco J; Garbutt JC
Alcohol Clin Exp Res; 2013 Apr; 37(4):668-74. PubMed ID: 23134193
[TBL] [Abstract][Full Text] [Related]
4. A pragmatic trial of acamprosate in the treatment of alcohol dependence in primary care.
Kiritzé-Topor P; Huas D; Rosenzweig C; Comte S; Paille F; Lehert P
Alcohol Alcohol; 2004; 39(6):520-7. PubMed ID: 15304381
[TBL] [Abstract][Full Text] [Related]
5. Alcohol-use disorders and depression: results from individual patient data meta-analysis of the acamprosate-controlled studies.
Lejoyeux M; Lehert P
Alcohol Alcohol; 2011; 46(1):61-7. PubMed ID: 21118900
[TBL] [Abstract][Full Text] [Related]
6. Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study.
Mann K; Lemenager T; Hoffmann S; Reinhard I; Hermann D; Batra A; Berner M; Wodarz N; Heinz A; Smolka MN; Zimmermann US; Wellek S; Kiefer F; Anton RF;
Addict Biol; 2013 Nov; 18(6):937-46. PubMed ID: 23231446
[TBL] [Abstract][Full Text] [Related]
7. Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation.
Mason BJ; Goodman AM; Chabac S; Lehert P
J Psychiatr Res; 2006 Aug; 40(5):383-93. PubMed ID: 16546214
[TBL] [Abstract][Full Text] [Related]
8. Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.
Morley KC; Teesson M; Reid SC; Sannibale C; Thomson C; Phung N; Weltman M; Bell JR; Richardson K; Haber PS
Addiction; 2006 Oct; 101(10):1451-62. PubMed ID: 16968347
[TBL] [Abstract][Full Text] [Related]
9. Acamprosate treatment in a long-term community-based alcohol rehabilitation programme.
Poldrugo F
Addiction; 1997 Nov; 92(11):1537-46. PubMed ID: 9519495
[TBL] [Abstract][Full Text] [Related]
10. The effects of combined acamprosate and integrative behaviour therapy in the outpatient treatment of alcohol dependence: a randomized controlled trial.
Wölwer W; Frommann N; Jänner M; Franke PE; Scherbaum N; Lieb B; Falkai P; Wobrock T; Kuhlmann T; Radermacher M; Maier W; Schütz C; Ohmann C; Burtscheidt W; Gaebel W
Drug Alcohol Depend; 2011 Nov; 118(2-3):417-22. PubMed ID: 21621929
[TBL] [Abstract][Full Text] [Related]
11. United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol.
Chick J; Howlett H; Morgan MY; Ritson B
Alcohol Alcohol; 2000; 35(2):176-87. PubMed ID: 10787394
[TBL] [Abstract][Full Text] [Related]
12. The effect of acamprosate on alcohol and food craving in patients with alcohol dependence.
Han DH; Lyool IK; Sung YH; Lee SH; Renshaw PF
Drug Alcohol Depend; 2008 Mar; 93(3):279-83. PubMed ID: 17983709
[TBL] [Abstract][Full Text] [Related]
13. Urinary ethyl glucuronide and ethyl sulfate testing for recent drinking in alcohol-dependent outpatients treated with acamprosate or placebo.
Dahl H; Hammarberg A; Franck J; Helander A
Alcohol Alcohol; 2011; 46(5):553-7. PubMed ID: 21616946
[TBL] [Abstract][Full Text] [Related]
14. Acamprosate for the treatment of alcohol dependence.
Boothby LA; Doering PL
Clin Ther; 2005 Jun; 27(6):695-714. PubMed ID: 16117977
[TBL] [Abstract][Full Text] [Related]
15. Effects of acamprosate on cognition in a treatment study of patients with schizophrenia spectrum disorders and comorbid alcohol dependence.
Ralevski E; O'Brien E; Jane JS; Dean E; Dwan R; Petrakis I
J Nerv Ment Dis; 2011 Jul; 199(7):499-505. PubMed ID: 21716064
[TBL] [Abstract][Full Text] [Related]
16. A pilot study on the effects of treatment with acamprosate on craving for alcohol in alcohol-dependent patients.
Weinstein A; Feldtkeller B; Feeney A; Lingford-Hughes A; Nutt D
Addict Biol; 2003 Jun; 8(2):229-32. PubMed ID: 12850782
[TBL] [Abstract][Full Text] [Related]
17. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials.
Snyder JL; Bowers TG
Am J Drug Alcohol Abuse; 2008; 34(4):449-61. PubMed ID: 18584575
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis.
Mann K; Lehert P; Morgan MY
Alcohol Clin Exp Res; 2004 Jan; 28(1):51-63. PubMed ID: 14745302
[TBL] [Abstract][Full Text] [Related]
20. A pilot study of oxcarbazepine versus acamprosate in alcohol-dependent patients.
Croissant B; Diehl A; Klein O; Zambrano S; Nakovics H; Heinz A; Mann K
Alcohol Clin Exp Res; 2006 Apr; 30(4):630-5. PubMed ID: 16573580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
